Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Budesonide and the risk of pneumonia: a meta-analysis of individual patient data.

Sin DD, Tashkin D, Zhang X, Radner F, Sjöbring U, Thorén A, Calverley PM, Rennard SI.

Lancet. 2009 Aug 29;374(9691):712-9. doi: 10.1016/S0140-6736(09)61250-2.

PMID:
19716963
2.

Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.

Spencer S, Karner C, Cates CJ, Evans DJ.

Cochrane Database Syst Rev. 2011 Dec 7;(12):CD007033. doi: 10.1002/14651858.CD007033.pub3. Review.

PMID:
22161409
3.

Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.

Spencer S, Evans DJ, Karner C, Cates CJ.

Cochrane Database Syst Rev. 2011 Oct 5;(10):CD007033. doi: 10.1002/14651858.CD007033.pub2. Review. Update in: Cochrane Database Syst Rev. 2011;(12):CD007033.

PMID:
21975759
4.

Risk of new onset diabetes mellitus in patients with asthma or COPD taking inhaled corticosteroids.

O'Byrne PM, Rennard S, Gerstein H, Radner F, Peterson S, Lindberg B, Carlsson LG, Sin DD.

Respir Med. 2012 Nov;106(11):1487-93. doi: 10.1016/j.rmed.2012.07.011. Epub 2012 Aug 15. Review.

5.

Budesonide/formoterol vs. salmeterol/fluticasone in COPD: a systematic review and adjusted indirect comparison of pneumonia in randomised controlled trials.

Halpin DM, Gray J, Edwards SJ, Morais J, Singh D.

Int J Clin Pract. 2011 Jul;65(7):764-74. doi: 10.1111/j.1742-1241.2011.02685.x. Review.

PMID:
21676119
6.

Combined corticosteroid and long acting beta-agonist in one inhaler for chronic obstructive pulmonary disease.

Nannini L, Cates CJ, Lasserson TJ, Poole P.

Cochrane Database Syst Rev. 2004;(3):CD003794. Review. Update in: Cochrane Database Syst Rev. 2007;(4):CD003794.

PMID:
15266502
7.

A systematic review of the cardiovascular risk of inhaled anticholinergics in patients with COPD.

Hilleman DE, Malesker MA, Morrow LE, Schuller D.

Int J Chron Obstruct Pulmon Dis. 2009;4:253-63. Epub 2009 Jul 20. Review.

8.

Long-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease: a meta-analysis.

Singh S, Amin AV, Loke YK.

Arch Intern Med. 2009 Feb 9;169(3):219-29. doi: 10.1001/archinternmed.2008.550. Review.

PMID:
19204211
9.

Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.

Keam SJ, Keating GM.

Treat Respir Med. 2004;3(4):247-68. Review.

PMID:
15350163
10.

Budesonide and formoterol in a single pressurized metered-dose inhaler for treatment of COPD.

Tashkin DP.

Expert Rev Respir Med. 2010 Dec;4(6):703-14. doi: 10.1586/ers.10.77. Review.

PMID:
21128746
11.

Combined corticosteroid and longacting beta-agonist in one inhaler for chronic obstructive pulmonary disease.

Nannini L, Lasserson TJ, Poole P.

Cochrane Database Syst Rev. 2003;(4):CD003794. Review. Update in: Cochrane Database Syst Rev. 2004;(3):CD003794.

PMID:
14583994
12.

[Risk of pneumonia with inhaled corticosteroids for stable chronic obstructive pulmonary disease patients].

Ruiz García V, Compte Torrero L.

Med Clin (Barc). 2011 Sep 17;137(7):302-4. doi: 10.1016/j.medcli.2010.10.026. Epub 2011 Mar 10. Review. Spanish.

PMID:
21396667
13.

The risk and outcomes of pneumonia in patients on inhaled corticosteroids.

Sibila O, Soto-Gomez N, Restrepo MI.

Pulm Pharmacol Ther. 2015 Jun;32:130-6. doi: 10.1016/j.pupt.2015.04.001. Epub 2015 May 5. Review.

14.
15.

Meta-review: adverse effects of inhaled corticosteroids relevant to older patients.

Mattishent K, Thavarajah M, Blanco P, Gilbert D, Wilson AM, Loke YK.

Drugs. 2014 Apr;74(5):539-47. doi: 10.1007/s40265-014-0202-z. Review.

PMID:
24659375

Supplemental Content

Support Center